R.M. Davis Inc’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
R.M. Davis Inc's BIIB Position: Q4 2018 in Review
R.M. Davis Inc sold out of Biogen (BIIB) in Q4 2018, closing a stake of 1,227 shares — an estimated $434K sold.
R.M. Davis Inc first reported a position in BIIB in Q3 2014 and held it in 17 quarters. The position peaked at $1.2M in Q2 2018. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.
- R.M. Davis Inc reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
- R.M. Davis Inc sold 1,227 Biogen shares in Q4 2018, an estimated $434K.
- R.M. Davis Inc first reported a position in Biogen in Q3 2014 and held it in 17 quarters.
- R.M. Davis Inc's Biogen position peaked at $1.2M in Q2 2018.
- 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.
Based on R.M. Davis Inc's 13F filing for Q4 2018, filed 18 Jan 2019.